European Society of Cardiology

News

ESC26: Heart attack reclassification rights gender imbalance

New definitions of myocardial infarction released at ESC 2026 recognise that there are different causes - and could lead to better treatment of women.

News

ESC26: Isomab safety evidence on blood vessel growth for CAD

Isomab has presented landmark safety data at ESC, clearing the path for next-generation therapies to promote blood vessel growth in CAD.

R&D

Why physiological pacing is changing the future of cardiac r...

Increasingly, electrophysiologists are exploring approaches that activate the heart through its intrinsic conduction pathways.

News

ESC: Study says GLP-1s treat heart failure AND cut emissions

Add a beneficial impact on climate change to the long list of benefits being attributed to GLP-1 agonist medicines.

News

New heart attack data boost AZ’s Brilinta

A new sub-analysis of data from a phase 3 trial shows AstraZeneca’s Brilinta cuts the risk of cardiovascular death by 29% in high risk patients.

ESC26: Heart attack reclassification rights gender imbalance

ESC26: Isomab safety evidence on blood vessel growth for CAD

Why physiological pacing is changing the future of cardiac r...

ESC: Study says GLP-1s treat heart failure AND cut emissions

New heart attack data boost AZ’s Brilinta

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

European Society of Cardiology

Editor's Picks